Diagnosis and Management of Post-Partum Hemorrhage Caused by Acquired Hemophilia A: A Case Report
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Acquired hemophilia A (AHA) is an uncommon autoimmune bleeding disorder in which autoantibodies that affect the functions of factor VIII (FVIII) are present in the blood. The initial diagnosis of AHA is difficult as the presentations of AHA differ from those of congenital hemophilia A. Moreover, the treatment of AHA is more complex due to the presence of autoantibodies against FVIII. Here, we present a case report of postpartum AHA, to increase the perception and knowledge regarding the recognition and management of such cases. We present a young female with the chief complaint of vaginal bleeding and upper arm ecchymosis. Laboratory results exhibited isolated prolonged activated partial thromboplastin time (APTT) and FVIII inhibitors. The patient was treated with corticosteroids, FVIII concentrates, and a bypassing agent. In conclusion, unexplained postpartum bleeding, unmanageable with basic hemostatic measures, should lead to clinical suspicion of an acquired bleeding disease.
Abstract
Acquired hemophilia A (AHA) is an uncommon autoimmune bleeding disorder in which autoantibodies that affect the functions of factor VIII (FVIII) are present in the blood. The initial diagnosis of AHA is difficult as the presentations of AHA differ from those of congenital hemophilia A. Moreover, the treatment of AHA is more complex due to the presence of autoantibodies against FVIII. Here, we present a case report of postpartum AHA, to increase the perception and knowledge regarding the recognition and management of such cases. We present a young female with the chief complaint of vaginal bleeding and upper arm ecchymosis. Laboratory results exhibited isolated prolonged activated partial thromboplastin time (APTT) and FVIII inhibitors. The patient was treated with corticosteroids, FVIII concentrates, and a bypassing agent. In conclusion, unexplained postpartum bleeding, unmanageable with basic hemostatic measures, should lead to clinical suspicion of an acquired bleeding disease.
참고문헌 (14)
- Ma AD, "Acquired factor VIII inhibitors : pathophysiology and treatment", Hematology Am Soc Hematol Educ Program, 2006, pp.432~437 (2006)[DOI]
- Charlebois J, "Management of acquired hemophilia A : review of current evidence", Transfus Apher Sci, 57, pp.717~720 (2018)[DOI]
- W Collins P, "Diagnosis and management of acquired coagulation inhibitors : a guideline from UKHCDO", Br J Haematol, 162, pp.758~773 (2013)[DOI]
- Knoebl P, "Demographic and clinical data in acquired hemophilia A : results from the European Acquired Haemophilia Registry(EACH2)", J Thromb Haemo, 10, pp.622~631 (2012)[DOI]
- Sallah S, "Inhibitors against factor VIII in patients with cancer", Analysis of 41 patients. Cancer, 91, pp.1067~1074 (2001)[DOI]
- O’Connor CR, "Systematic review of the presentation of coagulation factor VIII inhibitors in rheumatic diseases : a potential cause of life-threatening hemorrhage", Semin Arthritis Rheum, 44, pp.695~709 (2015)[DOI]
- Green D, "A survey of 215 nonhemophilic patients with inhibitors to Factor VIII", Thromb Haemost, 45, pp.200~203 (1981)
- Al-Shbool G, "Acquired hemophilia A presenting as intramuscular hematoma", J Investig Med High Impact Case Rep, 6, pp.1~4 (2018)[DOI]
- Franchini M, "Acquired haemophilia A : a 2013update", Thromb Haemost, 110, pp.1114~1120 (2013)[DOI]
- Mulliez SM, "Acquired hemophilia : a case report and review of the literature", Int J Lab Hematol, 36, pp.398~407 (2014)[DOI]
- Borg JY, "Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l’Hémophilie Acquise) registry", Haemophilia, 19, pp.564~570 (2013)[DOI]
- Rinaldi I, "Diagnosis and management of acquired hemophilia A : case reports and a literature review", Case Rep Med, 2021, pp.5554664~ (2021)[DOI]
- Collins PW, "Advances in the understanding of acquired haemophilia A : implications for clinical practice", Br J Haematol, 148, pp.183~194 (2010)
- Collins PW, "Acquired hemophilia A in the United Kingdom : a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organisation", Blood, 109, pp.1870~1877 (2007)[DOI]